Moxifloxacin and Bromfenac Eye Drop
|
Generic Name |
Moxifloxacin and Bromfenac |
|---|---|
|
Strength |
0.5% w/v + 0.09% w/v |
|
Form |
Eye Drop |
|
Packaging |
Bottle of 5 ml |
|
Therapeutic use |
Bacterial Infections, conjunctivitis |
|
Manufacturing Period |
30 to 45 Days |
Available Composition of
| Name | Strength | Therapeutic use | View More |
|---|---|---|---|
| Moxifloxacin Tablet | 400 mg | Respiratory tract infection, Skin Infection | |
| Moxifloxacin Infusion | 400mg/100ml | Bacterial Infections | |
| Moxifloxacin Eye Drop | 0.5% w/v | Analgesic, Anti-Inflammatory, conjunctivitis | |
| Moxifloxacin and Prednisolone Eye Drop | 0.5% w/v + 1% w/v | Analgesic, Anti-Inflammatory, Bacterial Infections | |
| Moxifloxacin and Loteprednol Etabonate Eye Drop | 0.5% w/v + 0.5% w/v | Analgesic, Anti-Inflammatory, Bacterial Infections, conjunctivitis | |
| Moxifloxacin and Ketrolac Tromethamine Eye Drop | 0.5% w/v + 0.5% w/v | Analgesic, Anti-Inflammatory, Bacterial Infections | |
| Moxifloxacin and Dexamethasone Eye Drop | 0.5% w/v + 0.1% w/v | conjunctivitis | |
| Moxifloxacin and Bromfenac Eye Drop | 0.5% w/v + 0.09% w/v | Bacterial Infections, conjunctivitis | |
| Bromfenac Eye Drop | 0.09% w/v | Nonsteroidal anti-inflammatory drugs |
Product Description For Moxifloxacin and Bromfenac Eye Drop
products details and uses
Moxifloxacin and Bromfenac Eye Drop Exporter India, Manufacturer and Global Supplier
As a trusted Moxifloxacin and Bromfenac Eye Drop Exporter India, we specialize in delivering high-quality ophthalmic formulations that ensure effective treatment for bacterial eye infections and post-operative inflammation. Manufactured under WHO-GMP certified facilities, our eye drops are widely recommended by healthcare professionals across the globe for their proven efficacy and safety standards.
Uses of Moxifloxacin and Bromfenac Eye Drop
-
Post-Operative Care: Widely prescribed after cataract surgery to prevent bacterial infections and control inflammation.
-
Bacterial Conjunctivitis: Helps treat red, irritated, and watery eyes caused by bacterial infection.
-
Eye Pain & Swelling: Reduces inflammation, discomfort, and sensitivity following eye procedures.
-
Preventive Therapy: Reduces the risk of complications in patients prone to recurrent eye infections.
Through our role as a leading Moxifloxacin and Bromfenac Eye Drop Exporter India, we supply hospitals, clinics, and distributors worldwide to ensure timely access to effective ophthalmic care.
Precautions for Use
-
Use only under the supervision of a qualified ophthalmologist.
-
Avoid touching the dropper tip to prevent contamination.
-
Contact lenses should not be worn while using this medication unless advised by a doctor.
-
Patients with a history of hypersensitivity to quinolones or NSAIDs should avoid this formulation.
-
Prolonged or unnecessary use may lead to resistance or reduced effectiveness.
Our responsibility as a Moxifloxacin and Bromfenac Eye Drop Exporter India is not only to supply medicines but also to ensure safe usage by providing essential guidelines and regulatory support.
Possible Side Effects
Like all medicines, Moxifloxacin and Bromfenac Eye Drops may cause some mild and temporary side effects, including:
-
Eye irritation or burning sensation
-
Temporary blurred vision
-
Dry eyes or watery eyes
-
Mild headache or eye discomfort
In rare cases, serious allergic reactions may occur, such as swelling of the eyelids, severe redness, or persistent pain. Patients should immediately consult their healthcare provider if these symptoms arise.
Why Choose Us as Your Export Partner?
-
WHO-GMP certified manufacturing facilities
-
Global distribution network covering Asia, Africa, Middle East, and Latin America
-
Customized packaging and labeling solutions
-
Dedicated support for tender documentation and product registration
Global Distribution Network
With a strong logistics and compliance framework, we successfully export to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.